Clinical Trial

Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 24, 2023 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with bladder cancer who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future bladder cancer patients and play an active role in advancing medical research.
Trial Details
NCT Number NCT06009510
Lead Sponsor Power Life Sciences Inc.
Conditions Bladder Cancer
Enrollment 500 participants
Start Date 2024-09
Primary Completion 2025-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2023-08-24